Q32 Bio Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Morrison Jodie Pope | CEO | Sale | 22,506 | $3.46 | $77,871 | 99,000 | Dec 2, 2025 |
| Kalowski Lee | CFO and President | Sale | 9,072 | $3.46 | $31,389 | 39,938 | Dec 2, 2025 |
| Morrison Jodie Pope | CEO | Sale | 10,494 | $1.80 | $18,889 | 121,506 | Aug 26, 2025 |
| Violette Shelia M. | Chief Scientific Officer | Sale | 2,990 | $1.80 | $5,382 | 58,384 | Aug 26, 2025 |
| Kalowski Lee | CFO and President | Sale | 4,240 | $1.80 | $7,632 | 49,010 | Aug 26, 2025 |
| Kalowski Lee | CFO and President | Award / Grant | 53,250 | — | — | 53,250 | Feb 24, 2025 |
| Morrison Jodie Pope | CEO | Award / Grant | 132,000 | — | — | 132,000 | Feb 24, 2025 |
| Campagna Jason | Chief Medical Officer | Award / Grant | 37,500 | — | — | 37,500 | Feb 24, 2025 |
| Violette Shelia M. | Chief Scientific Officer | Award / Grant | 37,500 | — | — | 61,374 | Feb 24, 2025 |
| Violette Shelia M. | Chief Scientific Officer | Option Exercise | 6,000 | $7.29 | $43,740 | 23,874 | Oct 11, 2024 |
| Violette Shelia M. | Chief Scientific Officer | Option Exercise | 13,300 | $3.12 | $41,496 | 13,300 | Oct 8, 2024 |
| Alloway Paul | See Remarks | Option Exercise | 23,530 | — | — | 51,566 | Mar 25, 2024 |
| Michaud Charles Jr | See Remarks | Option Exercise | 6,448 | — | — | 18,046 | Mar 25, 2024 |
| Alloway Paul | See Remarks | Sale | 268 | $24.21 | $6,488 | 2,596 | Mar 25, 2024 |
| Michaud Charles Jr | See Remarks | Sale | 75 | $24.20 | $1,815 | 927 | Mar 25, 2024 |
| TZIANABOS ARTHUR | — | Sale | 265 | $24.20 | $6,413 | 7,983 | Mar 25, 2024 |
| Alloway Paul | See Remarks | Sale | 7,280 | $0.57 | $4,150 | 28,036 | Jan 3, 2024 |
| Michaud Charles Jr | See Remarks | Sale | 1,708 | $0.57 | $974 | 11,598 | Jan 3, 2024 |
| TZIANABOS ARTHUR | — | Sale | 13,037 | $0.57 | $7,431 | 128,778 | Jan 1, 2024 |
| Michaud Charles Jr | See Remarks | Option Exercise | 1,056 | — | — | 10,666 | Jan 1, 2024 |
| Alloway Paul | See Remarks | Option Exercise | 8,910 | — | — | 35,316 | Jan 1, 2024 |
| Seymour Albert | See Remarks | Sale | 1,448 | $1.15 | $1,665 | 150,874 | Sep 6, 2023 |
| Jordan Julie | Chief Medical Officer | Sale | 109 | $1.39 | $152 | 4,160 | Aug 3, 2023 |
| Jordan Julie | Chief Medical Officer | Option Exercise | 350 | — | — | 2,869 | Aug 2, 2023 |
| Alloway Paul | See Remarks | Sale | 10,965 | $1.45 | $15,899 | 16,706 | Mar 2, 2023 |
| Blum Michael Lee | Chief Commercial Officer | Sale | 2,454 | $1.39 | $3,411 | 13,538 | Jan 9, 2023 |
| Alloway Paul | See Remarks | Sale | 3,090 | $1.39 | $4,295 | 20,103 | Jan 9, 2023 |
| Smith W Bradford | See Remarks | Sale | 3,729 | $1.39 | $5,183 | 14,219 | Jan 9, 2023 |
| Seymour Albert | See Remarks | Sale | 3,620 | $1.39 | $5,032 | 143,166 | Jan 9, 2023 |
| TZIANABOS ARTHUR | — | Sale | 10,616 | $1.39 | $14,756 | 108,395 | Jan 9, 2023 |
| Blum Michael Lee | Chief Commercial Officer | Option Exercise | 2,640 | — | — | 11,042 | Jan 1, 2023 |
| TZIANABOS ARTHUR | — | Option Exercise | 19,140 | — | — | 119,011 | Jan 1, 2023 |
| Seymour Albert | See Remarks | Option Exercise | 6,930 | — | — | 146,786 | Jan 1, 2023 |
| Smith W Bradford | See Remarks | Option Exercise | 6,930 | — | — | 17,948 | Jan 1, 2023 |
| Alloway Paul | See Remarks | Option Exercise | 5,280 | — | — | 23,193 | Jan 1, 2023 |
| Seymour Albert | Chief Scientific Officer | Option Exercise | 4,290 | — | — | 133,307 | Jan 5, 2022 |
| Smith W Bradford | CFO & Treasurer | Sale | 2,182 | $3.78 | $8,248 | 4,418 | Jan 1, 2022 |
| Kelly Timothy P | Chief Operating Officer | Sale | 1,406 | $3.78 | $5,315 | 2,224 | Jan 1, 2022 |
| Cohn Gabriel | Chief Medical Officer | Sale | 1,661 | $3.78 | $6,279 | 2,629 | Jan 1, 2022 |
| TZIANABOS ARTHUR | President & CEO | Sale | 5,354 | $3.78 | $20,238 | 86,011 | Jan 1, 2022 |
| Kelly Timothy P | See Remarks. | Sale | 54 | $7.70 | $416 | — | Sep 3, 2021 |
| Kelly Timothy P | See Remarks. | Option Exercise | 2,000 | $6.63 | $13,260 | 4,232 | Mar 1, 2021 |
| Kelly Timothy P | See Remarks | Sale | 6,232 | $11.16 | $69,549 | — | Mar 1, 2021 |
| Smith W Bradford | CFO & Treasurer | Option Exercise | 13,500 | $0.64 | $8,640 | 13,500 | Feb 8, 2021 |
| Kelly Timothy P | See Remarks | Sale | 500 | $13.00 | $6,500 | — | Feb 2, 2021 |
| Kelly Timothy P | See Remarks | Sale | 4,000 | $12.37 | $49,480 | — | Feb 1, 2021 |
| Kelly Timothy P | See Remarks | Option Exercise | 500 | $6.63 | $3,315 | 500 | Jan 12, 2021 |
| Seymour Albert | Chief Scientific Officer | Sale | 9,897 | $12.06 | $119,358 | 134,120 | Jan 7, 2021 |
| Seymour Albert | Chief Scientific Officer | Sale | 10,000 | $11.44 | $114,400 | 144,017 | Jan 5, 2021 |
| Kelly Timothy P | See Remarks | Option Exercise | 2,000 | $2.89 | $5,780 | 4,000 | Jan 4, 2021 |